Antonio M Gotto. Show Affiliations »
Abstract
Mesh: See more » Anticholesteremic Agents/adverse effectsAnticholesteremic Agents/therapeutic useCreatine Kinase/bloodHumansHydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effectsHydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic useLiver/drug effectsLiver/enzymologyLovastatin/adverse effectsLovastatin/therapeutic useMeta-Analysis as TopicMuscular Diseases/chemically inducedPravastatin/adverse effectsPravastatin/therapeutic usePyridines/adverse effectsPyridines/therapeutic useRandomized Controlled Trials as TopicRetrospective StudiesRhabdomyolysis/chemically inducedTransaminases/bloodTreatment Outcome
Substances: See more » Anticholesteremic AgentsHydroxymethylglutaryl-CoA Reductase InhibitorsPyridinesLovastatincerivastatinTransaminasesCreatine KinasePravastatin
Year: 2003 PMID: 12639194 DOI: 10.1001/archinte.163.6.657
Source DB: PubMed Journal: Arch Intern Med ISSN: 0003-9926